Citations for
1ANKRD1, IRF3
Ankyrin repeat domain 1 regulates innate immune responses against herpes simplex virus 1: A potential role in eczema herpeticum.
Bin L, Li X, Richers B, Streib JE, Hu JW, Taylor P, Leung DYM.
J Allergy Clin Immunol 141(6):2085-2093.e1. doi: 10.1016/j.jaci.2018.01.001. Epub 2018 Jan 31. 2018
2ANKRD1, RASSF1, YAP1
The tumor suppressor RASSF1A induces the YAP1 target gene ANKRD1 that is epigenetically inactivated in human cancers and inhibits tumor growth.
Jiménez AP, Traum A, Boettger T, Hackstein H, Richter AM, Dammann RH.
Oncotarget 8(51):88437-88452. doi: 10.18632/oncotarget.18177. eCollection 2017 Oct 24. 2017
3ANKRD1, YAP1
The protective role of YAP1 on ER stress-induced cell death in vascular smooth muscle cells.
Takaguri A, Kubo T, Mori M, Satoh K.
Eur J Pharmacol 815:470-477. doi: 10.1016/j.ejphar.2017.09.033. Epub 2017 Sep 23. 2017
4ANKRD1
Ankyrin Repeat Domain 1 Protein: A Functionally Pleiotropic Protein with Cardiac Biomarker Potential.
Ling SSM, Chen YT, Wang J, Richards AM, Liew OW.
Int J Mol Sci 18(7). pii: E1362. doi: 10.3390/ijms18071362. Review. 2017
5ANKRD1, MAPK7
ERK5 induces ankrd1 for catecholamine biosynthesis and homeostasis in adrenal medullary cells.
Obara Y, Nagasawa R, Nemoto W, Pellegrino MJ, Takahashi M, Habecker BA, Stork PJS, Ichiyanagi O, Ito H, Tomita Y, Ishii K, Nakahata N.
Cell Signal 28(3):177-189. doi: 10.1016/j.cellsig.2015.12.016. Epub 2015 Dec 29. 2016
6ANKRD1, BCL2
Cardiac ankyrin repeat protein attenuates cardiomyocyte apoptosis by upregulation of Bcl-2 expression.
Zhang N, Ye F, Zhu W, Hu D, Xiao C, Nan J, Su S, Wang Y, Liu M, Gao K, Hu X, Chen J, Yu H, Xie X, Wang J.
Biochim Biophys Acta 1863(12):3040-3049. doi: 10.1016/j.bbamcr.2016.09.024. Epub 2016 Oct 3. 2016
7ANKRD1
ANKRD1 modulates inflammatory responses in C2C12 myoblasts through feedback inhibition of NF-κB signaling activity.
Liu XH, Bauman WA, Cardozo C.
Biochem Biophys Res Commun 464(1):208-13. doi: 10.1016/j.bbrc.2015.06.118. Epub 2015 Jun 20. 2015
8ANKRD1
Overexpression of ankyrin repeat domain 1 enhances cardiomyocyte apoptosis by promoting p53 activation and mitochondrial dysfunction in rodents.
Shen L, Chen C, Wei X, Li X, Luo G, Zhang J, Bin J, Huang X, Cao S, Li G, Liao Y.
Clin Sci (Lond) 128(10):665-78. doi: 10.1042/CS20140586. 2015
9ANKRD1
Inhibition of ANKRD1 sensitizes human ovarian cancer cells to endoplasmic reticulum stress-induced apoptosis.
Lei Y, Henderson BR, Emmanuel C, Harnett PR, deFazio A.
Oncogene 34(4):485-95. doi: 10.1038/onc.2013.566. Epub 2014 Feb 17. 2015
10ANKRD1, MMP13
ANKRD1 acts as a transcriptional repressor of MMP13 via the AP-1 site.
Almodóvar-García K, Kwon M, Samaras SE, Davidson JM.
Mol Cell Biol 34(8):1500-11. doi: 10.1128/MCB.01357-13. Epub 2014 Feb 10. 2014
11ANKRD1, ANKRD2
Ankrd1 is a transcriptional repressor for the androgen receptor that is downregulated by testosterone.
Wu Y, Ruggiero CL, Bauman WA, Cardozo C.
Biochem Biophys Res Commun 437(3):355-60. doi: 10.1016/j.bbrc.2013.06.079. Epub 2013 Jun 28. 2013
12ANKRD1
Cardiac ankyrin repeat protein attenuates cardiac hypertrophy by inhibition of ERK1/2 and TGF-β signaling pathways.
Song Y, Xu J, Li Y, Jia C, Ma X, Zhang L, Xie X, Zhang Y, Gao X, Zhang Y, Zhu D.
PLoS One 7(12):e50436. doi: 10.1371/journal.pone.0050436. Epub 2012 Dec 5. 2012
13ANKRD1, DES
Loss of desmin triggers mechanosensitivity and up-regulation of Ankrd1 expression through Akt-NF-κB signaling pathway in smooth muscle cells.
Mohamed JS, Boriek AM.
FASEB J 26(2):757-65. doi: 10.1096/fj.10-160291. Epub 2011 Nov 15. 2012
14ANKRD1, ANKRD2
Muscle ankyrin repeat proteins: their role in striated muscle function in health and disease.
Kojic S, Radojkovic D, Faulkner G.
Crit Rev Clin Lab Sci 48(5-6):269-94. doi: 10.3109/10408363.2011.643857. Review. 2011
15ANKRD1
A novel role for cardiac ankyrin repeat protein Ankrd1/CARP as a co-activator of the p53 tumor suppressor protein.
Kojic S, Nestorovic A, Rakicevic L, Belgrano A, Stankovic M, Divac A, Faulkner G.
Arch Biochem Biophys 502(1):60-7. doi: 10.1016/j.abb.2010.06.029. Epub 2010 Jul 3. 2010
16ANKRD1
Intron retention generates ANKRD1 splice variants that are co-regulated with the main transcript in normal and failing myocardium.
Torrado M, Iglesias R, Nespereira B, Centeno A, López E, Mikhailov AT.
Gene 440(1-2):28-41. Epub 2009 Mar 31. 2009
17ANKRD1
Intracellular ANKRD1 protein levels are regulated by 26S proteasome-mediated degradation.
Badi I, Cinquetti R, Frascoli M, Parolini C, Chiesa G, Taramelli R, Acquati F.
FEBS Lett 583(15):2486-92. Epub 2009 Jul 8. 2009
18ANKRD1
Transcriptional deregulation and a missense mutation define ANKRD1 as a candidate gene for total anomalous pulmonary venous return.
Cinquetti R, Badi I, Campione M, Bortoletto E, Chiesa G, Parolini C, Camesasca C, Russo A, Taramelli R, Acquati F.
Hum Mutat 29(4):468-74. 2008
19ANKRD1
Ankyrin repeat domain 1, ANKRD1, a novel determinant of cisplatin sensitivity expressed in ovarian cancer.
Scurr LL, Guminski AD, Chiew YE, Balleine RL, Sharma R, Lei Y, Pryor K, Wain GV, Brand A, Byth K, Kennedy C, Rizos H, Harnett PR, deFazio A.
Clin Cancer Res 14(21):6924-32. 2008
20ANKRD1
Upregulated expression of cardiac ankyrin-repeated protein in renal podocytes is associated with proteinuria severity in lupus nephritis.
Matsuura K, Uesugi N, Hijiya N, Uchida T, Moriyama M.
Hum Pathol 38(3):410-9. Epub 2007 Jan 19. 2007
21ANKRD1
Cardiac ankyrin repeat protein (CARP) expression in human and murine atherosclerotic lesions: activin induces CARP in smooth muscle cells.
de Waard V, van Achterberg TA, Beauchamp NJ, Pannekoek H, de Vries CJ.
Arterioscler Thromb Vasc Biol 23(1):64-8. 2003
22ANKRD1
Cardiac ankyrin repeat protein, a negative regulator of cardiac gene expression, is augmented in human heart failure.
Zolk O, Frohme M, Maurer A, Kluxen FW, Hentsch B, Zubakov D, Hoheisel JD, Zucker IH, Pepe S, Eschenhagen T.
Biochem Biophys Res Commun 293(5):1377-82. 2002
23ANKRD1
Identification and characterization of a novel cytokine-inducible nuclear protein from human endothelial cells.
Chu W, Burns DK, Swerlick RA, Presky DH.
J Biol Chem 270(17):10236-45. 1995